RupeestopAbout UsNewsletter

Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 19 Aug 2026. Factsheet Jun 2026. About · Disclosures

Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment

Baroda BNP Paribas Mutual Fund
Sectoral Pharma and HealthcareDirectIDCW
NAV

₹10.927

As on 19 Aug 2026

Vs category

PeriodThis fundCategoryRank
1 year+10.29%
3 year+8.05%
5 year+8.05%

All Sectoral Pharma and Healthcare funds · Baroda BNP Paribas Mutual Fund

Returns

From NAVs through 19 Aug 2026

1Y
+10.29%
Total
3Y
+8.05%
p.a.
5Y
+8.05%
p.a.
SI
+8.05%
p.a.

Calendar years

-4.50%
2025
+14.42%
2026 YTD

Fund facts

Fund details from the Jun 2026 factsheet

Fund size
₹544.17 Cr
Expense ratio
0.61%
Exit load
None
Lock-in
None
Launched26 Jun 2025
StructureOpen Ended
ISININF251K01VC1

Where the money is invested

Split by asset type.

By asset type

Equity97.41%
Cash2.59%

What the fund holds

38 holdings · portfolio as on 30 May 2026

  • Sun Pharmaceuticals Industries Ltd
    Healthcare
    9.09%
  • Lupin Ltd
    Healthcare
    5.83%
  • Laurus Labs Ltd
    Healthcare
    5.76%
  • Abbott India Ltd
    Healthcare
    5.43%
  • Torrent Pharmaceuticals Ltd
    Healthcare
    5.27%
  • Ipca Laboratories Ltd
    Healthcare
    5.18%
  • Apollo Hospitals Enterprise Ltd
    Healthcare
    4.66%
  • J.B. Chemicals & Pharmaceuticals Ltd
    Healthcare
    4.38%
  • Fortis Healthcare Ltd
    Healthcare
    4.27%
  • Astrazeneca Pharma India Ltd
    Healthcare
    4.12%

Concentration

Top 5 weight
31.38%
Top 10 weight
53.99%
Avg turnover
43.33%

Risk and quality measures

How steady the returns have been.

Return quality

Sharpe
-0.03
Below category avg 0.48
Alpha
-5.65
Return above the benchmark

Risk

Std deviation
13.02%
How much returns swing
Beta
0.82
Better than category avg 0.94
R-squared
96.3%
How closely it tracks the benchmark

Who manages this fund

1 fund manager

  • SC
    Sanjay Chawla
    16.4 years in the industry
    Runs 15 schemes

Other versions

  • directIDCW
    Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Payout
    NAV ₹9.91
  • regularIDCW
    Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Payout
    NAV ₹9.85
  • directGrowth
    Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth
    NAV ₹9.91
  • regularGrowth
    Baroda BNP Paribas Health and Wellness Fund - Regular Plan - Growth
    NAV ₹9.85

FAQ

What is Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment NAV today?

The latest NAV of Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment is ₹10.927 as on 19 Aug 2026.

How has Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment performed vs its category?

1-year return +10.29%. Past performance does not guarantee future returns.

What are the returns of Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment?

Trailing returns from published NAVs: 1 year +10.29%, 3 year +8.05% a year, 5 year +8.05% a year, since our first NAV +8.05% a year. Past performance does not guarantee future returns.

How would a SIP in Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment have been illustrated?

The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +8.05%. It is not a forecast.

What is the expense ratio and fund size of Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment?

For Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment, the expense ratio is 0.61% and fund size (AUM) is ₹544.17 Cr.

What is the ISIN of Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment?

The ISIN for Baroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW Reinvestment is INF251K01VC1.

Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.

Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.